Symbol="PRQR"
AssetType="Common Stock"
Name="ProQR Therapeutics BV"
Description="ProQR Therapeutics NV, a biopharmaceutical company, is dedicated to the discovery and development of RNA-based therapies for the treatment of genetic disorders. The company is headquartered in Leiden, the Netherlands."
CIK="1612940"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="ZERNIKEDREEF 9, LEIDEN, NL"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="123427000"
EBITDA="-56298000"
PERatio="None"
PEGRatio="0"
BookValue="0.729"
DividendPerShare="0"
DividendYield="0"
EPS="-0.85"
RevenuePerShareTTM="0.058"
ProfitMargin="0"
OperatingMarginTTM="-13.37"
ReturnOnAssetsTTM="-0.205"
ReturnOnEquityTTM="-0.75"
RevenueTTM="4268000"
GrossProfitTTM="4802000"
DilutedEPSTTM="-0.85"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-0.434"
AnalystTargetPrice="3.93"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="29.24"
PriceToBookRatio="1.702"
EVToRevenue="9.84"
EVToEBITDA="-0.502"
Beta="0.0133"
num_52WeekHigh="3.85"
num_52WeekLow="0.722"
num_50DayMovingAverage="1.717"
num_200DayMovingAverage="2.1"
SharesOutstanding="80936000"
DividendDate="None"
ExDividendDate="None"
symbol="PRQR"
open="1.51"
high="1.53"
low="1.50"
price="1.50"
volume="125867.00"
latest_trading_day="2023-07-31"
previous_close="1.52"
change="-0.03"
change_percent="-1.6393%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="85"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="15"
Volume_recent_avg="629203"
Change_recent_avg="-0.01"
Delta_recent_avg="0.14"
Variance_recent_avg="0.07"
Change_ratio_recent_avg="-0.65"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="15"
Aroon_momentum_negative="85"
image_negative_thumbnail_id_1="105"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0071.jpeg"
image_negative_thumbnail_id_2="1103"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0136.jpeg"
image_neutral_thumbnail_id_1="556"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0043.jpeg"
image_neutral_thumbnail_id_2="570"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0029.jpeg"
image_positive_thumbnail_id_1="983"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0145.jpeg"
image_positive_thumbnail_id_2="954"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0116.jpeg"
image_professor_thumbnail_id_1="1171"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0005.jpeg"
image_professor_thumbnail_id_2="1199"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0033.jpeg"
